SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 186 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $355,500 | -24.8% | 2,250 | -38.4% | 0.01% | -25.0% |
Q1 2024 | $472,529 | +34.2% | 3,650 | -0.0% | 0.01% | +33.3% |
Q4 2023 | $352,066 | -20.5% | 3,651 | -0.1% | 0.01% | -33.3% |
Q3 2023 | $443,059 | +5.9% | 3,655 | 0.0% | 0.01% | +12.5% |
Q2 2023 | $418,571 | -16.8% | 3,655 | +0.1% | 0.01% | -27.3% |
Q1 2023 | $503,080 | +6.4% | 3,650 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $472,967 | +9.5% | 3,650 | -6.4% | 0.01% | +10.0% |
Q3 2022 | $432,000 | +44.5% | 3,900 | -2.1% | 0.01% | +66.7% |
Q2 2022 | $299,000 | -4.2% | 3,984 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $312,000 | -13.3% | 3,984 | -0.4% | 0.01% | 0.0% |
Q4 2021 | $360,000 | -1.9% | 3,999 | +0.7% | 0.01% | -14.3% |
Q3 2021 | $367,000 | +16.1% | 3,972 | -2.2% | 0.01% | +16.7% |
Q2 2021 | $316,000 | -52.1% | 4,062 | -54.2% | 0.01% | -53.8% |
Q1 2021 | $660,000 | -55.0% | 8,864 | +3.0% | 0.01% | -58.1% |
Q4 2020 | $1,467,000 | +25.7% | 8,604 | +3.5% | 0.03% | +6.9% |
Q3 2020 | $1,167,000 | -13.3% | 8,310 | -1.0% | 0.03% | -17.1% |
Q2 2020 | $1,346,000 | +88.5% | 8,394 | +14.9% | 0.04% | +59.1% |
Q1 2020 | $714,000 | -20.9% | 7,307 | +4.4% | 0.02% | 0.0% |
Q4 2019 | $903,000 | +67.8% | 6,998 | -2.0% | 0.02% | +46.7% |
Q3 2019 | $538,000 | -59.2% | 7,140 | -17.8% | 0.02% | -58.3% |
Q2 2019 | $1,319,000 | +16.5% | 8,683 | -8.6% | 0.04% | +20.0% |
Q1 2019 | $1,132,000 | -4.7% | 9,498 | -12.7% | 0.03% | -18.9% |
Q4 2018 | $1,188,000 | -50.9% | 10,881 | -27.4% | 0.04% | -40.3% |
Q3 2018 | $2,422,000 | +18.1% | 14,996 | -3.3% | 0.06% | +10.7% |
Q2 2018 | $2,050,000 | +31.2% | 15,507 | -26.5% | 0.06% | +40.0% |
Q1 2018 | $1,563,000 | -14.4% | 21,100 | -35.7% | 0.04% | -14.9% |
Q4 2017 | $1,826,000 | +19.8% | 32,830 | -2.3% | 0.05% | +14.6% |
Q3 2017 | $1,524,000 | +105.9% | 33,592 | +53.0% | 0.04% | +105.0% |
Q2 2017 | $740,000 | +9.8% | 21,953 | -3.6% | 0.02% | +5.3% |
Q1 2017 | $674,000 | +66.4% | 22,772 | +244.9% | 0.02% | +58.3% |
Q3 2016 | $405,000 | +5.2% | 6,602 | -67.3% | 0.01% | +9.1% |
Q2 2016 | $385,000 | +13.6% | 20,213 | +130.2% | 0.01% | +10.0% |
Q4 2015 | $339,000 | +17.3% | 8,779 | -2.2% | 0.01% | +11.1% |
Q3 2015 | $289,000 | -6.5% | 8,979 | -11.7% | 0.01% | 0.0% |
Q2 2015 | $309,000 | -51.9% | 10,172 | -79.0% | 0.01% | -47.1% |
Q1 2015 | $642,000 | +31.8% | 48,340 | +43.4% | 0.02% | +21.4% |
Q4 2014 | $487,000 | +104.6% | 33,700 | +198.9% | 0.01% | +100.0% |
Q3 2014 | $238,000 | -37.5% | 11,275 | +12.5% | 0.01% | -53.3% |
Q2 2013 | $381,000 | – | 10,019 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |